1-3 of 3
Koen Debackere
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic Targeting of JAK/STAT Signaling and Histone Acetyltransferase Activity in Post-Myeloproliferative Neoplasm Secondary AML

Kalay Bertulfo, Koen Debackere, Hannah Miller, Ryan Najac, Cindy Ma, Adolfo A. Ferrando, Teresa Palomero
Journal: Blood
Blood (2023) 142 (Supplement 1): 2792.
https://doi.org/10.1182/blood-2023-181099
Published: 2023
Journal Articles

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma

Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, Quentin Van Thillo, Nienke Meeuws, Cristina Prieto, Sarah Provost, Nicole Mentens, Kris Jacobs, Olga Gielen, David Nittner, Seishi Ogawa, Keisuke Kataoka, Carlos Graux, Thomas Tousseyn, Jan Cools, Daan Dierickx
Journal: Blood
Blood (2022) 140 (23): 2463–2476.
https://doi.org/10.1182/blood.2022016428
Published: 2022
Includes: Supplemental data
Journal Articles

FER and FES tyrosine kinase fusions in follicular T-cell lymphoma

Koen Debackere, Jo-Anne van der Krogt, Thomas Tousseyn, Julio Antonio Finalet Ferreiro, Katrien Van Roosbroeck, Lukas Marcelis, Carlos Graux, Daan Dierickx, Geneviève Ameye, Peter Vandenberghe, Lucienne Michaux, Jan Cools, Iwona Wlodarska
Journal: Blood
Blood (2020) 135 (8): 584–588.
https://doi.org/10.1182/blood.2019002401
Published: 2020
Includes: Supplemental data